Michael S. Orr
Impact in
- Toxicology top 5%
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 4
- Gene expression and cancer classification 4
- Cancer therapeutics and mechanisms 4
- Retinoids in leukemia and cellular processes 3
- Receptor Mechanisms and Signaling 3
- Nicotinic Acetylcholine Receptors Study 3
- Oncology 6
- Cancer-related Molecular Pathways 4
- Co-authors
- David A. Gewirtz (10 shared papers)Frank A. Fornari (7 shared papers)Joyce K. Randolph (7 shared papers)W. David Jarvis (3 shared papers)P M O'Connor (2 shared papers)Lijia Yu (2 shared papers)Steven Grant (2 shared papers)Sharon E. Straus (3 shared papers)
- Journals
- Biochemical Pharmacology (4 papers)Journal of Biological Chemistry (2 papers)Journal of the American Medical Informatics Association (1 paper)SLAS DISCOVERY (1 paper)Molecular Pharmacology (1 paper)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Michael S. Orr
26 papers receiving 683 citations
Peers
Comparison fields: 5 of 100
- Toxicology 40
- Oncology 214
- Molecular Biology 392
- Cancer Research 77
- Physiology 98
Countries citing papers authored by Michael S. Orr
This map shows the geographic impact of Michael S. Orr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Orr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Orr more than expected).
Fields of papers citing papers by Michael S. Orr
This network shows the impact of papers produced by Michael S. Orr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Orr. The network helps show where Michael S. Orr may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael S. Orr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 92 | |
| 2 | 2014 | 91 | |
| 3 | Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin. | 1994 | 77 |
| 4 | 2006 | 73 | |
| 5 | 1996 | 63 | |
| 6 | 2012 | 50 | |
| 7 | 2014 | 37 | |
| 8 | 2000 | 29 | |
| 9 | 2007 | 25 | |
| 10 | 1998 | 24 | |
| 11 | 1994 | 20 | |
| 12 | Dissociation between bulk damage to DNA and the antiproliferative activity of teniposide (VM-26) in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression. | 1993 | 19 |
| 13 | 2001 | 18 | |
| 14 | 1998 | 17 | |
| 15 | 2016 | 13 | |
| 16 | 1998 | 13 | |
| 17 | 1997 | 11 | |
| 18 | 1996 | 10 | |
| 19 | 1995 | 7 | |
| 20 | 2016 | 6 |
About Michael S. Orr
Michael S. Orr is a scholar working on Molecular Biology, Oncology, Toxicology, Cancer Research and Computational Theory and Mathematics, having authored 26 papers that have together received 717 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (4 papers), Gene expression and cancer classification (4 papers), Cancer-related Molecular Pathways (4 papers), Cancer therapeutics and mechanisms (4 papers), Retinoids in leukemia and cellular processes (3 papers), Receptor Mechanisms and Signaling (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Toxicology (40 citations), Oncology (214 citations), Molecular Biology (392 citations), Cancer Research (77 citations) and Physiology (98 citations). Michael S. Orr has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include David A. Gewirtz, Frank A. Fornari, Joyce K. Randolph, W. David Jarvis, P M O'Connor, Lijia Yu, Steven Grant, Sharon E. Straus, Helen Piwnica‐Worms and L. Orlandi. Their work appears in journals such as Biochemical Pharmacology, Journal of Biological Chemistry, Journal of the American Medical Informatics Association, SLAS DISCOVERY and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.